Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in Skin Sarcoidosis
NCT00305552Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2005
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cutaneous sarcoidosis comparing Thalidomide with Placebo (2 arms). Primary endpoint: Size of target skin lesions at 3 months. Started Feb 2005; status: completed.
02
Drugs
thalidomide
03
Conditions
cutaneous sarcoidosis
Beyond the preview
Go deeper on NCT00305552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00305552.